Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
clinical study
combination
commissioner
congress
crispr
crispr-cas9
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
editas medicine
eli lilly
ethics
failure
fda
furlough
gene editing
genetic alliance
genome editing
glaxosmithkline
government
he jiankui
house
What
big
2
×
bridge
2
×
accountability
act
bio
blog
bosley's
bosley’s
bucks
cas
ceo
civil
crime
crispr
data
departure
deregulate
editas
eff
exit
federal
fellow.recently
guiding
gutierrez
health
hipaa
insurance
intimate
invade
katrine
kenny
medicine
modifications
moves
ocr
office
personal
personnel
portability
post
Language
unset
Current search:
bridge
×
big
×
@eff.org
2 years ago
Big Data Profits If We Deregulate HIPAA
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More